BioAtla logo

BioAtla

BCAB | NASDAQ
Chart Builder DCF Calculator
$1.74
+$0.42 (+31.82%)
At close: Aug 28, 2026, 4:00 PM ET
+31.82%

Rating

Updated: Sep 30, 2026
47.8
+21.8 pts
Fundamentals Average
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $2.88M
1D Range
1.58 2.06
52W Range
1.07 71.50

Valuation (TTM)

PE -0.07
PB -0.08
EV/EBITDA -0.25

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $250.00
Loading financial charts...

Profile

BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cance...

Sector Healthcare
Industry Biotechnology
Employees 41
IPO Date Dec 16, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.